Cited by 295Bioinformatics and Genomic NetworksCancer Genomics and DiagnosticsGene expression and cancer classification

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index, and 1 are not checked yet.

Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes

Open access

Heo, Yong Jin, Hwa, Chanwoong, Lee, Gang-Hee, Park, Jae-Min, An, Joon-Yong·2021·Molecules and Cells

DOI 10.14348/molcells.2021.0042PMC PMC8334347

Open this paper in CoChat — free account Open PDF

Abstract

Multi-omics approaches are novel frameworks that integrate multiple omics datasets generated from the same patients to better understand the molecular and clinical features of cancers. A wide range of emerging omics and multi-view clustering algorithms now provide unprecedented opportunities to further classify cancers into subtypes, improve the survival prediction and therapeutic outcome of these subtypes, and understand key pathophysiological processes through different molecular layers. In this review, we overview the concept and rationale of multi-omics approaches in cancer research. We also introduce recent advances in the development of multi-omics algorithms and integration methods for multiple-layered datasets from cancer patients. Finally, we summarize the latest findings from large-scale multi-omics studies of various cancers and their implications for patient subtyping and drug development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.14348/molcells.2021.0042

Cites

88 of 89 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Overview of multi-omics approaches in cancer research. The integration of omics datasets is a crucial step in multi-omics studies. Datasets such as somatic mutations, CNV, gene expression, methylation, and proteome datasets are merged using various computational frameworks with distinct methods. The integration enables the comparison of molecular features across multiple viewpoints and the clustering of patients with relevant clinical features. Possible outcomes include enhanced identification of clinical subtypes, understanding of cancer pathophysiology, prediction of potential drug targets, and clinical decision support.CC BY-NC-SA · PubMed Central

Fig. 2 Latest findings in cancer multi-omics research. Multi-omics approaches integrate various high-throughput sequencing datasets across a range of molecular layers. Biological features are subject to multi-view clustering methods and account for distinct subtypes of cancer patients based on relevant clinical features.CC BY-NC-SA · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,965
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Patterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Similarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
Comparing protein abundance and mRNA expression levels on a genomic scale
Greenbaum, D. (2003) · Genome biology · doi:10.1186/gb-2003-4-9-117 · Cited by 1,692
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Integrative single-cell analysis
Stuart, T., & Satija, R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0093-7 · Cited by 1,460
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309
The transcriptional network for mesenchymal transformation of brain tumours
Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao, X., Snyder, E. Y., Sulman, E. P., Anne, S. L., Doetsch, F. K., Colman, H., et al. (2009) · Nature · doi:10.1038/nature08712 · Cited by 1,268
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029
From genomics to proteomics
Tyers, M., & Mann, M. (2003) · Nature · doi:10.1038/nature01510 · Cited by 1,026
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R. C., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M. A., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 964
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
Qiu, P., Simonds, E. F., Bendall, S. C., Gibbs, K. D., Bruggner, R. V., Linderman, M. D., Sachs, K., Nolan, G. P., & Plevritis, S. K. (2011) · Nature Biotechnology · doi:10.1038/nbt.1991 · Cited by 956
Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis
Shen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Basu, A. B., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I., Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S. Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.003 · Cited by 828
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Accumulation of driver and passenger mutations during tumor progression
Božić, I., Tibor Antal, A., Ohtsuki, H., Carter, H. K., Kim, D., Chen, S., Karchin, R., Kinzler, K. W., Vogelstein, B., & Nowak, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010978107 · Cited by 814
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
Vaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma
Sumazin, P., Yang, X., Chiu, H., Chung, W., Iyer, A. P., Llobet‐Navàs, D., Rajbhandari, P., Bansal, M., Guarnieri, P., Silva, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.041 · Cited by 695
The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.023 · Cited by 586
Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics
Lai, Z., Tsugawa, H., Wohlgemuth, G., Mehta, S. S., Mueller, M. R., Zheng, Y., Ogiwara, A., Meissen, J. K., Showalter, M. R., Takeuchi, K., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4512 · Cited by 575
Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis
Shen, R., Olshen, A. B., & Ladanyi, M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp659 · Cited by 564
Extensions of Sparse Canonical Correlation Analysis with Applications to Genomic Data
Witten, D., & Tibshirani, R. J. (2009) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1470 · Cited by 553
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 553
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators
Bodenmiller, B., Zunder, E. R., Finck, R., Chen, T. J., Savig, E. S., Bruggner, R. V., Simonds, E. F., Bendall, S. C., Sachs, K., Krutzik, P. O., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2317 · Cited by 546
Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies
Li, T., Kung, H., Mack, P. C., & Gandara, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3753 · Cited by 522
FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry
Palmer, A., Phapale, P. B., Chernyavsky, I., Lavigne, R., Fay, D., Tarasov, A., Kovalev, V., Fuchser, J., Nikolenko, S., Pineau, C., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4072 · Cited by 512
Synthetic lethality as an engine for cancer drug target discovery
Huang, A., Garraway, L. A., Ashworth, A., & Weber, B. L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0046-z · Cited by 490
A module of negative feedback regulators defines growth factor signaling
Amit, I., Citri, A., Shay, T., Lu, Y., Katz, M., Zhang, F., Tarcic, G., Siwak, D. R., Lahad, J. P., Jacob‐Hirsch, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1987 · Cited by 475
Pattern discovery and cancer gene identification in integrated cancer genomic data
Mo, Q., Wang, S., Seshan, V. E., Olshen, A. B., Schultz, N., Sander, C., Powers, R. S., Ladanyi, M., & Shen, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208949110 · Cited by 474 · cited 2×
“Since the runtime of iCluster increases with the number of features, iCluster+, providing full Bayesian regularization for clustering, has recently been proposed (Mo et al., 2013).”
Background
Synthetic lethal screen identification of chemosensitizer loci in cancer cells
Whitehurst, A. W., Bodemann, B. O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J. D., Michnoff, C. H., Hao, W., Roth, M. G., et al. (2007) · Nature · doi:10.1038/nature05697 · Cited by 471
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Chen, Y.-J., Roumeliotis, T. I., Chang, Y.-H., Chen, C.-T., Han, C.-L., Lin, M.-H., Chen, H.-W., Chang, G.-C., Chang, Y.-L., Wu, C.-T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.012 · Cited by 382
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Aguirre, A. J., Nowak, J. A., Camarda, N. D., Moffitt, R. A., Ghazani, A. A., Hazar-Rethinam, M., Raghavan, S., Kim, J., Brais, L. K., Ragon, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0275 · Cited by 367
A review on mass spectrometry-based quantitative proteomics: targeted and data independent acquisition
Vidova, V., & Spacil, Z. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.01.059 · Cited by 352
Target discovery
Lindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 343
Bayesian consensus clustering
Lock, E. F., & Dunson, D. B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt425 · Cited by 320
A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data
Yang, Z., & Michailidis, G. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv544 · Cited by 295
Proteogenomic Characterization of Human Early-Onset Gastric Cancer
Mun, D.-G., Bhin, J., Kim, S., Kim, H., Jung, J. H., Jung, Y., Jang, Y. E., Park, J. M., Kim, H., Jung, Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.003 · Cited by 294
Self-citation
Quantitative proteomics: challenges and opportunities in basic and applied research
Schubert, O. T., Röst, H. L., Collins, B. C., Rosenberger, G., & Aebersold, R. H. (2017) · Nature Protocols · doi:10.1038/nprot.2017.040 · Cited by 293
NEMO: cancer subtyping by integration of partial multi-omic data
Rappoport, N., & Shamir, R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz058 · Cited by 286
SALMON: survival analysis learning with multi-omics neural networks on breast cancer
Huang, Z., Zhan, X., Xiang, S., Johnson, T. S., Helm, B., Yu, C. Y., Zhang, J., Salama, P., Rizkalla, M., Han, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00166 · Cited by 262
A dream of single-cell proteomics
Marx, V. (2019) · Nature Methods · doi:10.1038/s41592-019-0540-6 · Cited by 250
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Hennessy, B. T., Lu, Y., Gonzalez-Angulo, A. M., Carey, M. S., Myhre, S., Ju, Z., Davies, M. A., Liu, W., Coombes, K. R., Meric‐Bernstam, F., et al. (2010) · Clinical Proteomics · doi:10.1007/s12014-010-9055-y · Cited by 241
Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: In Silico Modeling Integrates Imaging and Histology
Swanson, K. R., Rockne, R. C., Claridge, J., Chaplain, M. A. J., Alvord, E. C., & Anderson, A. R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1399 · Cited by 238
Bayesian correlated clustering to integrate multiple datasets
Kirk, P., Griffin, J. E., Savage, R. S., Ghahramani, Z., & Wild, D. L. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts595 · Cited by 236
Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification
Wu, D., Wang, D., Zhang, M. Q., & Gu, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-2223-8 · Cited by 233
Interplay of transcriptomics and proteomics
Hegde, P. S., White, I. R., & Debouck, C. M. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.006 · Cited by 230
Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis
Iadevaia, S., Lu, Y., Morales, F. C., Mills, G. B., & Ram, P. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0460 · Cited by 219
An omics perspective on drug target discovery platforms
Paananen, J., & Fortino, V. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz122 · Cited by 216
Defining principles of combination drug mechanisms of action
Pritchard, J. R., Bruno, P. M., Gilbert, L. A., Capron, K. L., Lauffenburger, D. A., & Hemann, M. T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210419110 · Cited by 164
Validating cancer drug targets
Benson, J. D., Chen, Y.-N. P., Cornell-Kennon, S., Dorsch, M., Kim, S., Leszczyniecka, M., Sellers, W. R., & Lengauer, C. (2006) · Nature · doi:10.1038/nature04873 · Cited by 162
Model‐driven multi‐omic data analysis elucidates metabolic immunomodulators of macrophage activation
Bordbar, A., Mo, M. L., Nakayasu, E. S., Schrimpe‐Rutledge, A. C., Kim, Y., Metz, T., Jones, M. B., Frank, B. C., Smith, R. D., Peterson, S. N., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.21 · Cited by 157
PINSPlus: a tool for tumor subtype discovery in integrated genomic data
Nguyen, H., Shrestha, S., Drăghici, S., & Nguyen, T. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty1049 · Cited by 145
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
Chen, Y., McGee, J., Chen, X., Doman, T. N., Gong, X., Zhang, Y., Hamm, N., Ma, X., Higgs, R. E., Bhagwat, S. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098293 · Cited by 138
iOmicsPASS: network-based integration of multiomics data for predictive subnetwork discovery
Koh, H. W. L., Fermin, D., Vogel, C., Choi, K. P., Ewing, R. M., & Choi, H. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0099-y · Cited by 131
Integrated genomic analyses of ovarian carcinoma
The Cancer Genome Atlas Research Network (2011) · Nature · doi:10.1038/nature10166 · Cited by 129
The glucose‐deprivation network counteracts lapatinib‐induced toxicity in resistant ErbB2‐positive breast cancer cells
Komurov, K., Tseng, J., Muller, M., Seviour, E. G., Moss, T. J., Yang, L., Nagrath, D., & Ram, P. T. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.25 · Cited by 117
Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism
Ramaswami, G., Won, H., Gandal, M. J., Haney, J., Wang, J. C., Wong, C. C. Y., Sun, W., Prabhakar, S., Mill, J., & Geschwind, D. H. (2020) · Nature Communications · doi:10.1038/s41467-020-18526-1 · Cited by 113
Multiview learning for understanding functional multiomics
Nguyen, N. D., & Wang, D. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007677 · Cited by 108
Bayesian Inference of Signaling Network Topology in a Cancer Cell Line
Hill, S. M., Lu, Y., Molina, J. R., Heiser, L. M., Spellman, P. T., Speed, T. P., Gray, J. W., Mills, G. B., & Mukherjee, S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts514 · Cited by 105
Patient-specific data fusion defines prognostic cancer subtypes
Yuan, Y., Savage, R. S., & Markowetz, F. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002227 · Cited by 97 · cited 2×
“Multi-omics frameworks are mostly based on Bayesian statistics (Kirk et al., 2012; Lock and Dunson, 2013; Shen et al., 2009; Vaske et al., 2010; Wu et al., 2015; Yuan et al., 2011), similarity networks (Nguyen et al.”
BackgroundMethod
Evaluation of integrative clustering methods for the analysis of multi-omics data
Chauvel, C., Novoloaca, A., Veyre, P., Reynier, F., & Becker, J. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz015 · Cited by 90
Combined experimental and computational analysis of DNA damage signaling reveals context‐dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress
Tentner, A. R., Lee, M. J., Ostheimer, G. J., Samson, L. D., Lauffenburger, D. A., & Yaffe, M. B. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.1 · Cited by 74
Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements
Pascal, J. A., Bearer, E. L., Wang, Z., Koay, E. J., Curley, S. A., & Vittorio Cristini, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300619110 · Cited by 65
Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling
Huang, S. C., Clarke, D. C., Gosline, S. J. C., Labadorf, A. T., Chouinard, C. R., Gordon, W., Lauffenburger, D. A., & Fraenkel, E. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002887 · Cited by 56
Understanding resistance to targeted cancer drugs through loss of function genetic screens
Berns, K., & Bernards, R. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.10.002 · Cited by 41
Systems Biology: Confronting the Complexity of Cancer
Gentles, A. J., & Gallahan, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1569 · Cited by 35
Mapping Cellular Coordinates through Advances in Spatial Transcriptomics Technology.
Teves, J. M., & Won, K. (2020) · PubMed Central · doi:10.14348/molcells.2020.0020 · Cited by 29
MONET: Multi-omic module discovery by omic selection
Rappoport, N., Safra, R., & Shamir, R. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008182 · Cited by 26 · cited 2×
“MONET (Multi Omic clustering by Non-Exhaustive Types) MONET is a method for detecting similar modules commonly present across multi-omics datasets (Rappoport et al., 2020).”
Method
Mechanisms of Macromolecular Interactions Mediated by Protein Intrinsic Disorder
Hong, S., Choi, S., Kim, R., & Koh, J. (2020) · Molecules and Cells · doi:10.14348/molcells.2020.0186 · Cited by 23
Multiomics profiling of paired primary and recurrent glioblastoma patient tissues
Dekker, L. J. M., Kannegieter, N. M., Haerkens, F., Toth, E., Kros, J. M., Hov, D. A. S., Fillebeen, J., Verschuren, L., Leenstra, S., Ressa, A., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa083 · Cited by 22
Single-Cell Toolkits Opening a New Era for Cell Engineering
Lee, S., Kim, J., & Park, J.-E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0002 · Cited by 20
Self-citation
Inferences of Individual Drug Response-Related Long Non-coding RNAs Based on Integrating Multi-omics Data in Breast Cancer
Cui, H., Kong, H., Peng, F., Wang, C., Zhang, D., Tian, J., & Zhang, L. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.038 · Cited by 18

Sorted by citations

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Xiong, N., Wu, H., & Yu, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1405491 · Cited by 227
Multi-OMICS approaches in cancer biology: New era in cancer therapy
Chakraborty, S., Sharma, G., Karmakar, S., & Banerjee, S. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167120 · Cited by 198
Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration
Wei, L., Niraula, D., Gates, E. D. H., Fu, J. Y., Luo, Y., Nyflot, M. J., Bowen, S. R., Naqa, I. M. E., & Cui, S. (2023) · British Journal of Radiology · doi:10.1259/bjr.20230211 · Cited by 179
A benchmark study of deep learning-based multi-omics data fusion methods for cancer
Leng, D., Zheng, L., Wen, Y., Zhang, Y., Wu, L., Wang, J., Wang, M., Zhang, Z., He, S., & Bo, X. (2022) · Genome biology · doi:10.1186/s13059-022-02739-2 · Cited by 163
MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis
Li, X., Ma, J., Leng, L., Han, M., Li, M., He, F., & Zhu, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.806842 · Cited by 161

See all 295

Authors: Heo, Y. J., Hwa, C., Lee, G.-H., Park, J.-M., & An, J.-Y.
Affiliations: Korea University (KR)
ORCID: Heo, Yong Jin
Hwa, Chanwoong
Lee, Gang-Hee
Park, Jae-Min
An, Joon-Yong
Venue: Molecules and Cells
Publisher: Elsevier BV
Published: 2021-07
Volume: 44
Issue: 7
Pages: 433-443
ISSN: 0219-1032 (ISSN-L)
1016-8478
DOI: 10.14348/molcells.2021.0042
PMC: PMC8334347
OpenAlex: W3180571536
Cited by: 294
References: 88
Citations by year: 2026: 66 · 2025: 81 · 2024: 75 · 2023: 56 · 2022: 15
FWCI: 3.86
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-sa/3.0/ (vor, 8 d)
Locations: Molecules and Cells (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Funders: National Research Foundation of Korea (2019M3E5D3073568)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Keywords: multi-omics integration, cancer subtyping, multi-view clustering, biological networks, survival prediction, therapeutic outcome prediction, drug development, cancer genomics
MeSH terms: Humans, Neoplasms, Survival Analysis, Computational Biology, Biomedical Research, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks